ArticleCell biochemistry and biophysics2026
Plasma-Activated Medium Suppresses Lung Cancer H1299 Cell Migration through the MAPK Pathway.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This research aimed to investigate the effect of PAM on the migration of lung cancer cells. Lactate dehydrogenase assays, colony formation assays, invasion assays, cell cycle assays, and self-developed microfluidic chips were used to thoroughly investigate the effects of PAM on H1299 cells. The results indicated that PAM treatment significantly increased the toxicity to lung cancer cells and induced cell cycle arrest at the G2/M phase. Conversely, the MAPK signaling pathway was observed to be regulated in lung cancer cells; therefore, their proliferation and migration were inhibited. The results of the microfluidic chip analysis, as well as invasion and colony formation assays, further corroborated the inhibitory effect of PAM on the migration and proliferation of H1299 cancer cells. These results reveal that PAM influences the biological behavior of lung cancer cells through migration, thus providing a theoretical basis for its potential therapeutic effect on lung cancer.
Indexed as
Identifiers
42234251What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.